skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

5 Total results for product and free and sample content found

In Vivo

Cancer Vaccines: Is There A Future Beyond Trial And Error?

By William Looney 12 Jul 2018

Strong foundational research in immunology and some promising early phase trial results have so far failed to expedite the validation of vaccines to treat cancer. In Vivo examines biopharma’s enduring optimism about the future of cancer vaccinology, including a closer look at one company’s platform to tackle the incurable malignancies that beset the mother of all organs: the human brain.

Topic Cancer Vaccines

Scrip

Missing In Action: China’s Best Shot In Ebola Vaccine Race

By Brian Yang 23 May 2018

As the Congo grapples with the latest outbreak of Ebola, China has approved its first domestically developed vaccine in record time, hailing it a national innovation champion. But as the World Health Organization starts vaccinations in Africa, can China make the cut and compete with global players including Merck & Co?

Topic Vaccines

Pink Sheet

Pfizer Staph Vaccine Trial May Support Claim For Some, But Not All, Orthopedic Surgeries

By Sue Sutter 08 Nov 2017

US FDA advisory committee members say if SA4Ag is efficacious in ongoing trial of spinal surgery patients.

Topic Vaccines

Pink Sheet

EU ‘Vaccine Hesitancy’ And Why It’s A Problem For Manufacturers And Public Health

By Ian Schofield 18 Oct 2017

“Vaccine hesitancy” – the gradual decline in rates of vaccination against preventable diseases – has led to outbreaks of illnesses

Topic Vaccines

Datamonitor Healthcare

PCSK9 inhibitors recommended for limited patient groups

By Louisa Joseph 22 Jun 2015

A US Food and Drug Administration (FDA) committee has endorsed Praluent (alirocumab; Sanofi/Regeneron) and Repatha (evolocumab; Amgen/Astellas) solely for high-risk hypercholesterol 

Topic Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: